Pediatric Countermeasures Ethical Insights

In Safeguarding Children Pediatric Medical Countermeasure Research, the Presidential Commission for the Study of Bioethical Issues responds to a critical inquiry from Health and Human Services Secretary Kathleen Sebelius. Following a 2012 recommendation for anthrax vaccine trials involving children, the Bioethics Commission thoroughly examines the ethical landscape surrounding such research. The report emphasizes that before any pediatric trials can ethically proceed, the federal government must undertake several essential measures. It firmly advises against pre-event trials with children until additional adult testing is completed, while also outlining stringent criteria that must be fulfilled for ethical pediatric research. Additionally, this report delves into the broader ethical considerations of pediatric medical countermeasures (MCM), encompassing federally-regulated drugs and products designed for use in response to chemical, biological, radiological, and nuclear threats.